Jiangsu Yangnong Chemical Co Ltd
Jiangsu Yangnong Chemical Co Ltd operates in the chemicals industry within the materials sector, generating revenue through its disclosed business activities.
Business. Jiangsu Yangnong Chemical Co Ltd operates in the chemicals industry within the materials sector, generating revenue through its disclosed business activities.
Analyst recommendations
11 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Jiangsu Yangnong Chemical Co Ltd operates in the chemicals industry within the materials sector, generating revenue through its disclosed business activities.
Jiangsu Yangnong Chemical Co Ltd maintains a conservative capital structure with a debt-to-equity ratio of 0.08, indicating minimal leverage relative to shareholder equity. The company holds total equity of 11.47 billion CNY against total liabilities of 6.72 billion CNY, resulting in a current ratio of 1.38. Despite the low leverage, the risk assessment flags medium liquidity risk and notes that net cash is negative after subtracting total debt, suggesting reliance on operating cash flows for liquidity management. Operating cash flow stands at 2.22 billion CNY, significantly higher than free cash flow of 748.6 million CNY, driven by capital expenditures of 961.3 million CNY.
Profitability metrics show a return on equity of 11.21% and a return on assets of 7.07%, reflecting efficient use of capital. The company generated net income of 1.29 billion CNY on revenue of 11.87 billion CNY, yielding a net margin of approximately 10.8%. Gross profit was 2.61 billion CNY, indicating a gross margin of roughly 22%, while operating income reached 1.51 billion CNY. Without cohort median data for direct comparison, these returns appear stable for a chemicals manufacturer, supported by a price-to-earnings ratio of 16.76 and an EV/EBITDA of 14.85.
Segment and geographic revenue mix data is not provided in the available input, preventing a detailed analysis of revenue concentration or regional exposure. The company’s business activity is broadly classified under chemicals, but specific product lines or customer concentrations are not disclosed in the current dataset.
Growth trajectory analysis is limited due to the absence of historical period data in the input. The current financial snapshot provides a single-period view of revenue and net income, but no year-over-year or quarterly trends are available to assess momentum or cyclicality.
Risk factors include medium liquidity risk and low dilution risk, with the primary concern being negative net cash position. The company has no significant dilution pressure, as basic and diluted shares outstanding are identical at 404.1 million shares. The key flag regarding negative net cash suggests that while the balance sheet is leveraged lightly, cash reserves may be constrained relative to total debt obligations.
Recent events are reflected in analyst estimates, with a mean price target of 81.01 CNY and a median target of 77.76 CNY, implying significant upside from the current market price of 53.33 CNY. The mean recommendation is 1.55, driven by 5 strong buy and 6 buy ratings, with no hold ratings, indicating strong analyst confidence in the company’s prospects.
- Conservative leverage with a debt-to-equity ratio of 0.08 and strong operating cash flow of 2.22 billion CNY.
- Profitability is solid with 11.21% ROE and 7.07% ROA, supported by 1.29 billion CNY in net income.
- Liquidity risk is flagged as medium due to negative net cash position despite a current ratio of 1.38.
- Analyst sentiment is overwhelmingly positive with a mean recommendation of 1.55 and significant upside to price targets.
- No dilution risk exists as basic and diluted share counts are identical.
- Historical growth trends and segment details are unavailable for deeper analysis.
Bull / Bear case
Generated · model-assistedAnalysts project 35.9% upside to a mean price target of 81.01, reflecting strong market confidence in the stock.
Net margin of 10.8% is well above the cohort median of 5.3%, demonstrating robust profitability compared to industry standards.
Return on equity of 11.2% outperforms the cohort median of 7.9%, highlighting effective capital utilization for shareholders.
Debt-to-equity ratio of 0.08 is in the top quartile for low leverage, suggesting a conservative and stable capital structure.
Free cash flow turned negative to -285 million CNY in FY2025, raising concerns about short-term liquidity generation capabilities.
The company faces a medium level of liquidity risk, which could constrain financial flexibility during market stress.
In focus — financials by report
Revenue ¥2.71B, +12,2% YoY; Operating income +17,9% YoY.
- ▍Revenue ¥2.71B, +12,2% YoY
- ▍Operating income +17,9% YoY
- ▍Net income +30,8% YoY
- ▍Net margin 8.5%
Revenue ¥2.92B, +26,1% YoY; Operating income −1,7% YoY.
- ▍Revenue ¥2.92B, +26,1% YoY
- ▍Operating income −1,7% YoY
- ▍Net income −5,0% YoY
- ▍Net margin 8.5%
Revenue ¥2.99B, +18,6% YoY; Operating income +12,6% YoY.
- ▍Revenue ¥2.99B, +18,6% YoY
- ▍Operating income +12,6% YoY
- ▍Net income +11,1% YoY
- ▍Net margin 12.4%
Revenue ¥3.24B; Operating income ¥518.2M.
- ▍Revenue ¥3.24B
- ▍Operating income ¥518.2M
- ▍Net margin 13.4%
Revenue ¥2.42B; Operating income ¥225.9M.
- ▍Revenue ¥2.42B
- ▍Operating income ¥225.9M
- ▍Net margin 7.3%
Revenue ¥2.32B; Operating income ¥298.7M.
- ▍Revenue ¥2.32B
- ▍Operating income ¥298.7M
- ▍Net margin 11.3%
Revenue ¥2.52B; Operating income ¥388.3M.
- ▍Revenue ¥2.52B
- ▍Operating income ¥388.3M
- ▍Net margin 13.2%
Revenue ¥11.87B, +13,8% YoY; Operating income +7,9% YoY.
- ▍Revenue ¥11.87B, +13,8% YoY
- ▍Operating income +7,9% YoY
- ▍Net income +7,0% YoY
- ▍Free cash flow +362,9% YoY
- ▍Net margin 10.8%
Revenue ¥10.43B, −9,1% YoY; Operating income −24,8% YoY.
- ▍Revenue ¥10.43B, −9,1% YoY
- ▍Operating income −24,8% YoY
- ▍Net income −23,2% YoY
- ▍Free cash flow −175,0% YoY
- ▍Net margin 11.5%
Revenue ¥11.48B, −27,4% YoY; Operating income −12,5% YoY.
- ▍Revenue ¥11.48B, −27,4% YoY
- ▍Operating income −12,5% YoY
- ▍Net income −12,8% YoY
- ▍Free cash flow −63,0% YoY
- ▍Net margin 13.6%
Revenue ¥15.81B, +33,5% YoY; Operating income +47,7% YoY.
- ▍Revenue ¥15.81B, +33,5% YoY
- ▍Operating income +47,7% YoY
- ▍Net income +46,8% YoY
- ▍Free cash flow +349,6% YoY
- ▍Net margin 11.3%
Revenue ¥11.84B; Operating income ¥1.44B.
- ▍Revenue ¥11.84B
- ▍Operating income ¥1.44B
- ▍Net margin 10.3%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 3,94 |
| Revenue | —no estimate | —no estimate | 13,7B CNY |
| Operating income | —no estimate | —no estimate | 1,8B CNY |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Reference data
- Ev To Operating Incomeenterprise_value / operating_income
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Enterprise Valuemarket_cap - net_cash
- Cash Conversion Ratiooperating_cash_flow / net_income
- Market Capmarket_price * shares_outstanding_diluted
- Jiangsu Yangnong Chemical Co Ltd Market data — financials · 2026-07-06
- Jiangsu Yangnong Chemical Co Ltd Market data — analyst estimates · 2026-07-06
- Jiangsu Yangnong Chemical Co Ltd Market data — ESG · 2026-07-06